Maximum Tolerated Dose of CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
- Study Title
- To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
- Teva Identifier
- C37440/1108
- ClinicalTrials.gov Identifier
- NCT01922752
- Study Status
- Completed
- Trial Condition(s)
- Solid Tumors
- Interventions
- Drug: CEP-37440
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 07/01/2013 - 12/01/2015
- Phase
- Phase 1
